U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980636) titled 'A Trial of Shengmai Liquid for Long COVID Fatigue.' on May 18.
Brief Summary: The goal of this clinical trial is to learn if Shengmai liquid works to treat Long Covid fatigue. It will also learn about the safety of Shengmai liquid. The main questions it aims to answer are:
* Dose the Shengmai liquid will reduce the level of fatigue in the participants and reduce the fatigue scale score of the participants?
* Dose the Shengmai liquid will reduce the level of anxiety and depression in the participants and improve the sleep quality and quality of life of the participants Researchers will compare Shengmai oral liquid to a placebo (a lo...